These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 21493743

  • 1. Long-term results of a randomized controlled trial in childhood IgA nephropathy.
    Kamei K, Nakanishi K, Ito S, Saito M, Sako M, Ishikura K, Hataya H, Honda M, Iijima K, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1301-7. PubMed ID: 21493743
    [Abstract] [Full Text] [Related]

  • 2. Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.
    Shima Y, Nakanishi K, Kamei K, Togawa H, Nozu K, Tanaka R, Sasaki S, Iijima K, Yoshikawa N.
    Nephrol Dial Transplant; 2011 Jan; 26(1):163-9. PubMed ID: 20601366
    [Abstract] [Full Text] [Related]

  • 3. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Yoshikawa N, Ito H, Sakai T, Takekoshi Y, Honda M, Awazu M, Ito K, Iitaka K, Koitabashi Y, Yamaoka K, Nakagawa K, Nakamura H, Matsuyama S, Seino Y, Takeda N, Hattori S, Ninomiya M.
    J Am Soc Nephrol; 1999 Jan; 10(1):101-9. PubMed ID: 9890315
    [Abstract] [Full Text] [Related]

  • 4. Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
    Shima Y, Nakanishi K, Kaku Y, Ishikura K, Hataya H, Matsuyama T, Honda M, Sako M, Nozu K, Tanaka R, Iijima K, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Pediatr Nephrol; 2018 Nov; 33(11):2103-2112. PubMed ID: 29987456
    [Abstract] [Full Text] [Related]

  • 5. Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial.
    Yoshikawa N, Honda M, Iijima K, Awazu M, Hattori S, Nakanishi K, Ito H, Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Clin J Am Soc Nephrol; 2006 May; 1(3):511-7. PubMed ID: 17699253
    [Abstract] [Full Text] [Related]

  • 6. Combined therapy with prednisolone, azathioprine, heparin-warfarin, and dipyridamole for paediatric patients with severe IgA nephropathy--is it relevant for adult patients?
    Yoshikawa N, Ito H.
    Nephrol Dial Transplant; 1999 May; 14(5):1097-9. PubMed ID: 10344344
    [No Abstract] [Full Text] [Related]

  • 7. Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study.
    Yoshikawa N, Nakanishi K, Ishikura K, Hataya H, Iijima K, Honda M, Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Pediatr Nephrol; 2008 May; 23(5):757-63. PubMed ID: 18224343
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for persistent proteinuria after a 2-year combination therapy for severe childhood IgA nephropathy.
    Kamei K, Nakanishi K, Ito S, Ishikura K, Hataya H, Honda M, Nozu K, Iijima K, Shima Y, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Group.
    Pediatr Nephrol; 2015 Jun; 30(6):961-7. PubMed ID: 25487669
    [Abstract] [Full Text] [Related]

  • 9. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
    Pozzi C, Andrulli S, Pani A, Scaini P, Roccatello D, Fogazzi G, Pecchini P, Rustichelli R, Finocchiaro P, Del Vecchio L, Locatelli F.
    J Nephrol; 2013 Jun; 26(1):86-93. PubMed ID: 22460183
    [Abstract] [Full Text] [Related]

  • 10. Progression of IgA nephropathy under current therapy regimen in a Chinese population.
    Li X, Liu Y, Lv J, Shi S, Liu L, Chen Y, Zhang H.
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):484-9. PubMed ID: 24408121
    [Abstract] [Full Text] [Related]

  • 11. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.
    Ballardie FW, Roberts ISD.
    J Am Soc Nephrol; 2002 Jan; 13(1):142-148. PubMed ID: 11752031
    [Abstract] [Full Text] [Related]

  • 12. Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study).
    Shima Y, Nakanishi K, Sako M, Saito-Oba M, Hamasaki Y, Hataya H, Honda M, Kamei K, Ishikura K, Ito S, Kaito H, Tanaka R, Nozu K, Nakamura H, Ohashi Y, Iijima K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children (JSKDC).
    Pediatr Nephrol; 2019 May; 34(5):837-846. PubMed ID: 30284023
    [Abstract] [Full Text] [Related]

  • 13. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
    Yagi K, Okada M, Yanagida H, Kuwajima H, Ikeda M, Sugimoto K, Takemura T.
    Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of prednisolone and mizoribine therapy for diffuse IgA nephropathy.
    Kawasaki Y, Suzuki J, Sakai N, Etoh S, Murai H, Nozawa R, Suzuki H.
    Am J Nephrol; 2004 Dec; 24(1):147-53. PubMed ID: 14726626
    [Abstract] [Full Text] [Related]

  • 15. Crescentic IgA nephropathy in children.
    Shima Y, Nakanishi K, Hama T, Mukaiyama H, Sato M, Tanaka Y, Tanaka R, Kaito H, Nozu K, Sako M, Iijima K, Yoshikawa N.
    Pediatr Nephrol; 2020 Jun; 35(6):1005-1014. PubMed ID: 31993782
    [Abstract] [Full Text] [Related]

  • 16. IgA nephropathy with presentation of nephrotic syndrome at onset in children.
    Shima Y, Nakanishi K, Sato M, Hama T, Mukaiyama H, Togawa H, Tanaka R, Nozu K, Sako M, Iijima K, Suzuki H, Yoshikawa N.
    Pediatr Nephrol; 2017 Mar; 32(3):457-465. PubMed ID: 27714465
    [Abstract] [Full Text] [Related]

  • 17. Immunosuppressive agents for treating IgA nephropathy.
    Vecchio M, Bonerba B, Palmer SC, Craig JC, Ruospo M, Samuels JA, Molony DA, Schena FP, Strippoli GF.
    Cochrane Database Syst Rev; 2015 Aug 03; (8):CD003965. PubMed ID: 26235292
    [Abstract] [Full Text] [Related]

  • 18. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S, Li JP.
    Trials; 2020 Jan 06; 21(1):31. PubMed ID: 31907076
    [Abstract] [Full Text] [Related]

  • 19. Improved renal survival in Japanese children with IgA nephropathy.
    Yata N, Nakanishi K, Shima Y, Togawa H, Obana M, Sako M, Nozu K, Tanaka R, Iijima K, Yoshikawa N.
    Pediatr Nephrol; 2008 Jun 06; 23(6):905-12. PubMed ID: 18224344
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria.
    Harmankaya O, Oztürk Y, Baştürk T, Obek A, Kiliçarslan I.
    Int Urol Nephrol; 2002 Jun 06; 33(1):167-71. PubMed ID: 12090325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.